Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 1/2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 3Breast 3Sarcoma 2Plasma cell 2Thoracic 1Lymphoid 1Head & Neck 1Dermatologic 1

Conditions

Sarcoma 211Bone Neoplasms 58Breast Neoplasms 40Neoplasms 39Osteosarcoma 37Lymphoma 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Gastrointestinal Stromal Tumors 31Dendritic Cell Sarcoma, Interdigitating 31Hodgkin Disease 29Lymphoma, Non-Hodgkin 27Leukemia 27Burkitt Lymphoma 25Melanoma 24Brain Neoplasms 24Multiple Myeloma 23Leukemia, Myeloid, Acute 23Sarcoma, Ewing 22Recurrence 21Lymphoma, Mantle-Cell 21Lymphoma, Large B-Cell, Diffuse 21Glioblastoma 21Neuroblastoma 20Lymphoma, Follicular 20Leukemia, Lymphocytic, Chronic, B-Cell 20Lymphoma, Large-Cell, Immunoblastic 18Gliosarcoma 18Sarcoma, Kaposi 17Prostatic Neoplasms 17Pancreatic Neoplasms 17

Interventions

apatinib 2Ifosfamide 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Drug-Related Side Effects and Adverse Reactions × Sarcoma × Clear all
NCT04690231 2022-03-15

Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma

Peking University People's Hospital

Phase NA Completed
79 enrolled
Sarcoma

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT04260113 2021-01-05

AIAC

Peking University People's Hospital

Phase NA Completed
40 enrolled
Sarcoma

Chondrosarcoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡